Literature DB >> 9005219

Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8.

S P Cobbold1, E Adams, S E Marshall, J D Davies, H Waldmann.   

Abstract

Over the last five years it has become increasingly clear that the peripheral immune system can maintain tolerance to both self and non-self antigens through a variety of mechanisms. Although clonal deletion may play an important part in limiting rapidly expanding responses, there are many examples where antigen reactive T cells remain. It has been proposed that tolerance is maintained in this situation either by the induction of anergy or by ongoing suppression. The phenomenon known as immune deviation, where non-inflammatory Th2 responses could suppress Th1 and positively reinforce themselves provided an attractive explanation for infectious tolerance, where tolerant T cells could guide further naive T cells also to tolerance. However, experiments to test this hypothesis in the models of CD4 and CD8 antibody-induced tolerance have given conflicting data, with no clear evidence of Th2 responses in tolerant mice. In this paper we review recent data that IL-4 plays a role in suppression, but that the source of IL-4 may not be the tolerant/suppressor T cell. We also discuss how infectious tolerance can operate on third party antigens if they are linked on the same antigen presenting cell and how CD4+ T cells can suppress CD8+ T-cell responses. Finally, we suggest a model of infectious anergy that is compatible with the available data.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9005219     DOI: 10.1111/j.1600-065x.1996.tb00897.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  28 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice.

Authors:  Y Ikehara; Y Yasunami; S Kodama; T Maki; M Nakano; T Nakayama; M Taniguchi; S Ikeda
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 3.  Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.

Authors:  A D Dick; J D Isaacs
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

4.  IL-4 expression delays eosinophil-independent vasculopathy and fibrosis during allograft rejection in the mouse.

Authors:  Edda M Roberts; De Shon Hall; Sharon Ferguson; Susan Minson; Joanna D Davies
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

5.  Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming.

Authors:  Audrea M Burns; Anita S Chong
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

6.  Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model.

Authors:  T Wang; E B Ahmed; L Chen; J Xu; J Tao; C-R Wang; M-L Alegre; A S Chong
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 7.  CD4 T cells in tumor immunity.

Authors:  Mara Gerloni; Maurizio Zanetti
Journal:  Springer Semin Immunopathol       Date:  2005-03-15

Review 8.  Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans.

Authors:  Maurizio Zanetti; Xavier Hernandez; Pierre Langlade-Demoyen
Journal:  Springer Semin Immunopathol       Date:  2005-02-15

9.  Regulation and privilege in transplantation tolerance.

Authors:  Herman Waldmann; Elizabeth Adams; Paul Fairchild; Stephen Cobbold
Journal:  J Clin Immunol       Date:  2008-09-06       Impact factor: 8.317

10.  Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.

Authors:  J H McIntosh; M Cochrane; S Cobbold; H Waldmann; S A Nathwani; A M Davidoff; A C Nathwani
Journal:  Gene Ther       Date:  2011-06-30       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.